Suppr超能文献

[血浆地高辛的简易快速测定。方法及临床评价]

[Simplified rapid determination of plasma digoxin. Methods and clinical evaluation].

作者信息

Kramer P, Saul J, Köthe E, Scheler F

出版信息

Klin Wochenschr. 1975 Mar 1;53(5):215-9. doi: 10.1007/BF01468810.

Abstract

The introduction of the Gamma Coat 125I-Digoxin Radioimmunoassay has simplified the digoxin determination to an extent that it may be used even in general hospitals with an intensive care unit. The total time for a stat determination has been reduced to 70 min. The coefficient of variation of the digoxin determination at low levels (less than 0.8 ng/ml) was less than 15% for simultaneous and repeated measurements even when using one of the inexpensive nuclear counting systems. At high levels (greater than 2.5 ng/ml) the coefficient of variation showed to be less than 6%. Hemolysis, low albumine concentration and other than digoxin-bound isotopes in the blood samples did not cause methologic problems. Provided that resorption and elimination kinetics of the different digoxin preparations were taken into account, digoxin levels of more than 2 ng/ml as measured by the Gamma Coat method in patients with normal renal function plasma were usually associated with clinical signs of overdosage; therapeutic concentrations were mostly higher than 1.2 ng/ml. The incidence of digitalis toxicity with high digoxin levels was lower in uremic than in normal patients. According to preliminary observations in dialysis patients this increase in tolerance to digitalis, may be a consequence of hyperkalemia and renal acidosis. Erroneously high digoxin concentrations were found in patients up to 2 hrs after injection of high doses of spironolactone (400-1000 mg) due to cross reaction. Therapeutic concentrations of digitoxin (10-25 ng/ml) caused only subtherapeutic digoxin concentrations of 0.4-0.9 ng/ml.

摘要

伽马涂层125I - 地高辛放射免疫分析法的引入,已将地高辛测定简化到了甚至可在设有重症监护病房的普通医院使用的程度。急诊测定的总时间已缩短至70分钟。即使使用一种价格低廉的核计数系统,在低水平(低于0.8纳克/毫升)时地高辛测定的变异系数对于同时测定和重复测定而言均小于15%。在高水平(高于2.5纳克/毫升)时,变异系数显示小于6%。血液样本中的溶血、低白蛋白浓度以及除地高辛结合同位素以外的物质并未引发方法学问题。只要考虑到不同地高辛制剂的吸收和消除动力学,通过伽马涂层法测得的肾功能正常患者血浆中地高辛水平超过2纳克/毫升通常与过量用药的临床体征相关;治疗浓度大多高于1.2纳克/毫升。尿毒症患者中地高辛水平高时洋地黄毒性的发生率低于正常患者。根据对透析患者的初步观察,对洋地黄耐受性的这种增加可能是高钾血症和肾性酸中毒的结果。由于交叉反应,在注射大剂量螺内酯(400 - 1000毫克)后长达2小时的患者中发现了错误的高地高辛浓度。洋地黄毒苷的治疗浓度(10 - 25纳克/毫升)仅导致0.4 - 0.9纳克/毫升的亚治疗性地高辛浓度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验